Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Boston Therapeutics, Inc. (BTHE) Reaches Agreement for Marketing SugarDown in the US

Today before the opening bell, Boston Therapeutics announced that it had signed a consulting agreement with Generosus Advisors, LLC and Fortified Management Group, LLC to market SugarDown® in the United States on a non-exclusive basis. The marketing of SugarDown will be done via the Help Now Networks, a healthcare marketing company, and its affiliates.

Kenneth A. Tassey, Jr., President, Boston Therapeutics, said, “In our marketing agreement for SugarDown in the United States, we are working with a company that has a broad knowledge of the needs of those who fit our ideal customer profile. HNN has created an impressive database of loyal members. We are confident that HNN will effectively communicate the benefits of SugarDown to these individuals and efficiently distribute the product when orders are placed.”

Thomas Scipione of Help Now Networks, added, “We are very excited to introduce SugarDown to our two million members. Over the past several years we have marketed many products that are beneficial to our members to help them better manage their disease. We plan to rollout a marketing campaign for SugarDown in the next few weeks. Help Now Networks is in the business of lead generation through digital media and telemarketing services. For the past five years HNN’s primary focus has been in healthcare of which diabetes has been our core campaign.”

As of now, Health Now Networks maintains a database of its affiliate of some 2 million members, of whom many fit SugarDown’s target market. SugarDown is an over-the-counter, chewable tablet that, when taken prior to meals, is designed to reduce post-meal elevation in glucose. The food supplement will be test-marketed via trained outbound call center outreach and electronic media. Health Now Networks will be managing fulfillment of all customer orders and other distribution channels.

For more information on Boston Therapeutics and SugarDown, visit:

Let us hear your thoughts:

This entry was posted in Boston Therapeutics Inc. BTHE. Bookmark the permalink.

Comments are closed.